Stay updated on Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new site revision label 'Revision: v3.4.2' and removed the government funding lapse notice along with the previous revision label 'Revision: v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary display option and updated UI/metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0) while removing older wording (Last Update Submitted that met QC Criteria; No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor page update: revision from v3.3.3 to v3.3.4; no changes to study content or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section with prefecture-level site listings (Aichi-ken, Fukuoka, Gifu, Gunma, Hiroshima, Hokkaido, Hyōgo, Kanagawa, Kumamoto, Nagasaki, Niigata, Osaka, Shizuoka, Tokyo, Toyama) and a general Locations heading. Removed the old per-prefecture 'X Locations' pages, indicating a reorganization of how study sites are presented.SummaryDifference1%

- Check85 days agoChange DetectedRevision: v3.3.2 is now shown, replacing Revision: v3.3.1. No changes to study details, eligibility criteria, or listed locations were observed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.